Key result
p47phox knockout prevents up to ~50% loss of diaphragm function in mice with CHF.
Why the study?
Does p47phox knockout prevent diaphragm contractile dysfunction in mice with chronic heart failure?
Population
Wild-type and p47phox knockout mice with chronic heart failure (CHF)
Comparison
p47phox knockout vs Wild-type mice with CHF
Design
Preclinical
Authors
Loading...
p47phox targeting may preserve diaphragm function in CHF; leaves open clinical translation pending human trials.
Does p47phox knockout prevent diaphragm contractile dysfunction in mice with chronic heart failure?
p-value: p=<0.05
p47phox knockout prevents diaphragm contractile dysfunction in a murine model of chronic heart failure, identifying p47phox-dependent NAD(P)H oxidase as a potential therapeutic target for CHF-related exercise intolerance.
Ahn et al. (2015) studied Chronic heart failure. p47(phox) knockout vs. Wild-type mice was evaluated on Diaphragm isometric force, shortening velocity, and peak power (p=<0.05). p47(phox) knockout prevented the 20-50% decrease in diaphragm isometric force, shortening velocity, and peak power elicited by chronic heart failure in mice (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: